Search

everythinglearnresearchcommunity

for

Search:↓

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Hair repigmentation can indicate malignancy and should be investigated.

Hirsutism in young girls can have various causes beyond PCOS, so diagnoses should be reconsidered if treatments don't work.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Androgens increase cervical cancer risk and affect its development.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

A mare had a functional ovary with a tumor containing cartilage and bone.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.